1Cell.Ai Marks Major Milestone with Successful CLIA Validation of OncoIncytes 1080-Gene NGS Panel 1Cell.Ai has concluded a successful CLIA validation study for its OncoIncytes 1080-gene NGS panel, enhancing cancer diagnostics with advanced profiling.

1Cell.Ai Marks Major Milestone with Successful CLIA Validation of OncoIncytes 1080-Gene NGS Panel #United_States #Foster_City #OncoIncytes #1Cell.Ai #NGS_panel

1Cell.Ai Revolutionizes Cancer Diagnostics with OncoIncytes for Precision Oncology 1Cell.Ai, previously known as OneCell Diagnostics, introduces OncoIncytes, a groundbreaking cancer diagnostic that leverages multi-modal data for enhanced precision oncology.

1Cell.Ai Revolutionizes Cancer Diagnostics with OncoIncytes for Precision Oncology #United_States #Foster_City #Precision_Oncology #OncoIncytes #1Cell.Ai